This protocol addresses sarcoidosis presenting alongside small fiber neuropathy — a distinct clinical subset in which a number of otherwise unexplained symptoms such as fatigue, pain, and cognitive dysfunction may be attributable to small fiber involvement.
In patients with sarcoidosis, small fiber neuropathy can drive significant symptom burden — including neuropathic pain — that does not respond predictably to standard anti-inflammatory therapies. Recognising this comorbidity shapes the therapeutic approach beyond typical sarcoidosis management.
Management in this setting involves a combination of agents targeting neuropathic symptoms alongside anti-inflammatory strategies. The full protocol specifies which agents to use and in what clinical context — only a partial overview is provided here.